Trial Profile
A phase I study of RGD-AAVP-TNF
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2019
Price :
$35
*
At a glance
- Drugs RGD-AAVP-TNF (Primary)
- Indications Cancer
- Focus Adverse reactions; First in man
- 04 Mar 2017 New trial record
- 09 Feb 2017 According to an AAVP Biosystems media release, the company is preparing to submit its IND application in 2017, and initiate its first in-human Phase I clinical study in 2018.